CompaniesCardiokine

Cardiokine

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

1,867

By Phase

PHASE2: 1PHASE3: 4PHASE1: 1

By Status

COMPLETED: 6WITHDRAWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00578695
NCT00660959
NCT00876798
NCT01055912
NCT01056848
Hover over trial bars to see details

Recent Trials

NCT01055912Lead Sponsor
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
PHASE2Completed
170 participants
Started: Jan 31, 2010
NCT01056848Lead Sponsor
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
N/ACompleted
135 participants
Started: Jan 31, 2010
NCT00876876Lead Sponsor
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
PHASE3Withdrawn
300 participants
Started: Jul 31, 2009 · Completed: Dec 31, 2010
NCT00876798Lead Sponsor
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
PHASE3Completed
206 participants
Started: Jun 30, 2009
NCT00675701Lead Sponsor
A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study
PHASE1Completed
298 participants
Started: May 31, 2008 · Completed: Oct 31, 2008
View all 7 trials →
Related Companies
Cornerstone Therapeutics 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired